SULFATRIM PEDIATRIC Drug Patent Profile
✉ Email this page to a colleague
When do Sulfatrim Pediatric patents expire, and when can generic versions of Sulfatrim Pediatric launch?
Sulfatrim Pediatric is a drug marketed by Pharm Assoc and is included in one NDA.
The generic ingredient in SULFATRIM PEDIATRIC is sulfamethoxazole; trimethoprim. There are twenty-seven drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the sulfamethoxazole; trimethoprim profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sulfatrim Pediatric
A generic version of SULFATRIM PEDIATRIC was approved as sulfamethoxazole; trimethoprim by SUN PHARM INDUSTRIES on August 25th, 1986.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for SULFATRIM PEDIATRIC?
- What are the global sales for SULFATRIM PEDIATRIC?
- What is Average Wholesale Price for SULFATRIM PEDIATRIC?
Summary for SULFATRIM PEDIATRIC
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 4 |
| Patent Applications: | 5,868 |
| DailyMed Link: | SULFATRIM PEDIATRIC at DailyMed |
Recent Clinical Trials for SULFATRIM PEDIATRIC
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Roswell Park Cancer Institute | Phase 4 |
| National Cancer Institute (NCI) | Phase 4 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 3 |
Pharmacology for SULFATRIM PEDIATRIC
US Patents and Regulatory Information for SULFATRIM PEDIATRIC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharm Assoc | SULFATRIM PEDIATRIC | sulfamethoxazole; trimethoprim | SUSPENSION;ORAL | 018615-001 | Jan 7, 1983 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
